Semaglutide & Tirzepatide Injections

Semaglutide Injections Fresno

Semaglutide is now available at Sylvan Med Spa in Fresno, CA. The #1 selling weight loss medication in the USA is now available at a significant cost savings.

Semaglutide is a GLP-1 receptor agonist similar to the naturally occurring hormone controlling your appetite. Semaglutide medication can control your appetite and prevent hunger pangs, thus supporting your weight loss goals. No restrictive diet or intense exercise is needed!

Semaglutide injections are a type of medicine that can help people who are overweight or obese lose weight. These injections mimic a hormone in the body that tells the brain to reduce appetite and increase feelings of fullness after meals. This means that people who receive semaglutide injections may feel less hungry and more satisfied after eating, which can help them to eat less and lose weight.

Studies have shown that Semaglutide injections are effective in helping people lose weight. People who receive these injections have been shown to lose 15% to 20% of their body weight in about six months. Semaglutide injections may also help to improve other health problems associated with obesity, such as high blood pressure and high cholesterol.

Overall, Semaglutide injections are a promising new tool for people struggling with obesity and have not been successful with traditional weight loss methods. If you want to learn more about Semaglutide injections and whether they might be a good option for you, call our office at 559-432-3438 or use your Book Online feature to schedule your appointment.

Tirzepatide Injections

Discover the most effective weight loss tool on the market. People using Tirzepatide lose more weight than any other GLP-1 product. Tirzepatide patients lose on average 22.5% of body weight in 72 weeks. GLP-1 agonists act on an area in the brain that regulates appetite. They make you feel full and satisfied, which reduces the amount you eat. 

How it works

Tirzepatide is a dual GIP and GLP-1 receptor agonist. This means, in addition to mimicking the effects of GLP-1, it also mimics the effects of the GIP (glucose-dependent insulinotropic polypeptide) hormone. The combined action on both receptors provides additional benefits for weight loss.

(function(w,d,t,r,u){w[u]=w[u]||[];w[u].push({'projectId':'10000','properties':{'pixelId':'10195361','he': '','hph': ''}});var s=d.createElement(t);s.src=r;s.async=true;s.onload=s.onreadystatechange=function(){var y,rs=this.readyState,c=w[u];if(rs&&rs!="complete"&&rs!="loaded"){return}try{y=YAHOO.ywa.I13N.fireBeacon;w[u]=[];w[u].push=function(p){y([p])};y(c)}catch(e){}};var scr=d.getElementsByTagName(t)[0],par=scr.parentNode;par.insertBefore(s,scr)})(window,document,"script","","dotq");